Outcome Capital LLC has expanded its biotech practice with the addition of Ellen Baron to its executive team.
Baron most recently was a managing director of biopharmaceuticals at Healthios Capital Markets LLC.
Outcome Capital adds to biotech practice
Street Talk | Episode 98: Regulatory scrutiny having cooling effect on community bank M&A
Insight Weekly: M&A outlook; US community bank margins; green hydrogen players' EU expansion
Street Talk | Episode 97: Recessionary fears still keeping bank investors on the sidelines
Making sanctions effective: Key themes for banks